...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM

There is no indication that Zenith has an AGM this quarter. 

BDAZ

Share
New Message
Please login to post a reply